Literature DB >> 15292329

Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.

Anna L Gloyn1, Elizabeth A Cummings, Emma L Edghill, Lorna W Harries, Rachel Scott, Teresa Costa, I Karen Temple, Andrew T Hattersley, Sian Ellard.   

Abstract

Activating mutations in the KCNJ11 gene encoding for the Kir6.2 subunit of the beta-cell ATP-sensitive potassium channel have recently been shown to be a common cause of permanent neonatal diabetes. In 80% of probands, these are isolated cases resulting from de novo mutations. We describe a family in which two affected paternal half-siblings were found to be heterozygous for the previously reported R201C mutation. Direct sequencing of leukocyte DNA showed that their clinically unaffected mothers and father were genotypically normal. Quantitative real-time PCR analysis of the father's leukocyte DNA detected no trace of mutant DNA. These results are consistent with the father being a mosaic for the mutation, which is restricted to his germline. This is the first report of germline mosaicism in any form of monogenic diabetes. The high percentage of permanent neonatal diabetes cases due to de novo KCNJ11 mutations suggests that germline mosaicism may be common. The possibility of germline mosaicism should be considered when counseling recurrence risks for the parents of a child with an apparently de novo KCNJ11 activating mutation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292329     DOI: 10.1210/jc.2004-0568

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

Review 1.  Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.

Authors:  Emma L Edghill; Sarah E Flanagan; Sian Ellard
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 2.  6q24 transient neonatal diabetes.

Authors:  I Karen Temple; Julian P H Shield
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 3.  ATP-sensitive potassium channelopathies: focus on insulin secretion.

Authors:  Frances M Ashcroft
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  DNA analysis: what and when to request?

Authors:  G Norbury; C J Norbury
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

5.  Modeling K,ATP--dependent excitability in pancreatic islets.

Authors:  Jonathan R Silva; Paige Cooper; Colin G Nichols
Journal:  Biophys J       Date:  2014-11-04       Impact factor: 4.033

6.  Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.

Authors:  Farzaneh Abbasi; Sadaf Saba; Azadeh Ebrahim-Habibi; Forough A Sayahpour; Parvin Amiri; Bagher Larijani; Mahsa M Amoli
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.074

7.  Precision medicine for a man presented with diabetes at 2-month old.

Authors:  Su Fen Ang; Clara Si Hua Tan; Jessie Choi Wan Fong; Su Chi Lim
Journal:  Eur J Hum Genet       Date:  2019-03-19       Impact factor: 4.246

8.  Diagnosis and treatment of neonatal diabetes: a United States experience.

Authors:  Julie Støy; Siri Atma W Greeley; Veronica P Paz; Honggang Ye; Ashley N Pastore; Kinga B Skowron; Rebecca B Lipton; Fran R Cogen; Graeme I Bell; Louis H Philipson
Journal:  Pediatr Diabetes       Date:  2008-07-25       Impact factor: 4.866

9.  Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus.

Authors:  Maria Sara Remedi; Harley T Kurata; Alexis Scott; F Thomas Wunderlich; Eva Rother; Andre Kleinridders; Ailing Tong; Jens C Brüning; Joseph C Koster; Colin G Nichols
Journal:  Cell Metab       Date:  2009-02       Impact factor: 27.287

10.  Permanent neonatal diabetes due to KCNJ11 gene mutation.

Authors:  S Letha; Darly Mammen; Joseph J Valamparampil
Journal:  Indian J Pediatr       Date:  2007-10       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.